Our physicians are amongst the most sought-after practitioners for the challenging infusion cases.
This includes helping patients in need of enzyme-replacement therapy and other rare conditions.
Fabrazyme (agalsidase beta) is just one of these specific therapies and is used to treat patients with fabry disease. It works by lowering the amount of globotriaosylceramide (gl-3), which builds up in cells lining the blood vessels of the kidney and certain other cells.
CALL 877.448.3627 FOR MORE INFORMATION OR TO SCHEDULE AN APPOINTMENT.